UBS Group’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$973K Buy
43,149
+33,095
+329% +$746K ﹤0.01% 4371
2025
Q1
$281K Buy
10,054
+9,852
+4,877% +$276K ﹤0.01% 5080
2024
Q4
$2.42K Sell
202
-146
-42% -$1.75K ﹤0.01% 7807
2024
Q3
$5.77K Sell
348
-1,378
-80% -$22.8K ﹤0.01% 6819
2024
Q2
$16.9K Buy
1,726
+1,076
+166% +$10.6K ﹤0.01% 6259
2024
Q1
$9.52K Buy
650
+571
+723% +$8.36K ﹤0.01% 6108
2023
Q4
$1.14K Sell
79
-465
-85% -$6.73K ﹤0.01% 7180
2023
Q3
$13K Buy
+544
New +$13K ﹤0.01% 5869
2023
Q1
Sell
-30
Closed -$2.46K 9161
2022
Q4
$2.46K Sell
30
-53
-64% -$4.35K ﹤0.01% 8476
2022
Q3
$8K Buy
83
+70
+538% +$6.75K ﹤0.01% 7657
2022
Q2
$2K Sell
13
-261
-95% -$40.2K ﹤0.01% 8594
2022
Q1
$67K Buy
+274
New +$67K ﹤0.01% 5205
2021
Q3
Sell
-14
Closed -$4K 8875
2021
Q2
$4K Sell
14
-710
-98% -$203K ﹤0.01% 7596
2021
Q1
$149K Sell
724
-14
-2% -$2.88K ﹤0.01% 4688
2020
Q4
$148K Buy
738
+150
+26% +$30.1K ﹤0.01% 4463
2020
Q3
$97K Sell
588
-280
-32% -$46.2K ﹤0.01% 4380
2020
Q2
$215K Sell
868
-83
-9% -$20.6K ﹤0.01% 3965
2020
Q1
$173K Buy
951
+219
+30% +$39.8K ﹤0.01% 4000
2019
Q4
$212K Buy
732
+274
+60% +$79.4K ﹤0.01% 4565
2019
Q3
$125K Buy
458
+298
+186% +$81.3K ﹤0.01% 4705
2019
Q2
$60K Buy
160
+120
+300% +$45K ﹤0.01% 4907
2019
Q1
$11K Sell
40
-335
-89% -$92.1K ﹤0.01% 5925
2018
Q4
$80K Buy
375
+218
+139% +$46.5K ﹤0.01% 4846
2018
Q3
$70K Buy
157
+76
+94% +$33.9K ﹤0.01% 5006
2018
Q2
$33K Buy
+81
New +$33K ﹤0.01% 5410
2018
Q1
Sell
-19
Closed -$12K 7100
2017
Q4
$12K Sell
19
-30
-61% -$18.9K ﹤0.01% 5946
2017
Q3
$23K Buy
+49
New +$23K ﹤0.01% 5455
2017
Q2
Sell
-20
Closed -$4K 6897
2017
Q1
$4K Sell
20
-92
-82% -$18.4K ﹤0.01% 6163
2016
Q4
$13K Buy
112
+94
+522% +$10.9K ﹤0.01% 5817
2016
Q3
$3K Buy
+18
New +$3K ﹤0.01% 6368
2016
Q1
Sell
-51
Closed -$9K 6904
2015
Q4
$9K Buy
+51
New +$9K ﹤0.01% 6069
2015
Q3
Sell
-76
Closed -$17K 6974
2015
Q2
$17K Buy
+76
New +$17K ﹤0.01% 5626